Gambaran Hasil Procalcitonin dan D-Dimer Pada Pasien Covid-19 Di RSUD Budhi Asih Jakarta Timur

Authors

  • Kamilia Gulin Permata Prodi Teknologi Laboratorium Medis, Fakultas Kesehatan, Universitas Mohammad Husni Thamrin, Jakarta, Indonesia, Indonesia
  • Catu Umirestu Nurdiani Prodi Teknologi Laboratorium Medis, Fakultas Kesehatan, Universitas Mohammad Husni Thamrin, Jakarta, Indonesia, Indonesia
  • Heru Purwanto Nugroho Prodi Teknologi Laboratorium Medis, Fakultas Kesehatan, Universitas Mohammad Husni Thamrin, Jakarta, Indonesia, Indonesia
  • Ellis Susanti Prodi Teknologi Laboratorium Medis, Fakultas Kesehatan, Universitas Mohammad Husni Thamrin, Jakarta, Indonesia, Indonesia

DOI:

https://doi.org/10.37012/anakes.v10i1.2088

Abstract

The World Health Organization (WHO) declared an epidemic caused by Coronavirus Disease – 19 (Covid-19) on January 9, 2020. The first case was found on December 30, 2019 in Wuhan, China. The virus spreads through droplets. Symptoms of COVID-19 start from shortness of breath, cough and fever. Patients who are confirmed with COVID-19 are then carried out laboratory tests in the form of Procalcitonin (PCT) and D-dimer. This study was conducted using a descriptive method whose data was taken from laboratory examination results for the period April 2022 - May 2023 as many as 54 PCT and D-dimer result data. The results of the frequency distribution examination were based on normal values, normal PCT levels as many as 24 patients (44%) and abnormal PCT levels as many as 30 patients (56%) and normal D-dimer levels as many as 23 patients (43%) and abnormal D-dimer levels as many as 31 patients (57%). The frequency distribution in COVID-19 patients based on gender, male as many as 28 patients (52%) while in women as many as 26 patients (48%).In this conclusion, the frequency distribution of PCT and D-dimer examinations based on gender, men are higher than women. PCT examination is more with abnormal values compared to normal values. D-dimer test results with abnormal values more than normal values.

Keyword            : Covid-19, D-dimer, PCT

References

Aditia, Arianda. (2021). “Covid-19 : Epidemiologi, Virologi, Penularan, Gejala Klinis, Diagnosa, Tatalaksana, Faktor Risiko dan Pencegahan.†Jurnal Penelitian Perawat Profesional 3(November): 653–60. http://jurnal.globalhealthsciencegroup.com/index.php/JPPP%0ACOVID-19.

Budiarti, novi yulia. (2020). “Latar Belakang Coronavirus Penyakit Mulai dari Gejala Ringan Sampai Gejala Berat.†Sustainability (Switzerland) 4(1): 1–9.https://pesquisa.bvsalud.org/portal/resource/en/mdl Ahttp://sersc.org/journals/index.php/IJAST/article.

Bwire, G. M. (2020). Coronavirus : Why Men are More Vulnerable to Covid-19 Than Women. SN Comprehensive Clinical Medicine. Vol 2, No. 7 :874–876. Dilihat 23 September 2021 https://doi.org/10.1007%2Fs42399-020-00341-w

Damo, N. Y. (2021). Diagnostic Coronavirus Disease 2019 (COVID-19) dengan Pemeriksaan Laboratorium Mikrobiologi Klinik. eBiomedik, 77-86.

Friska O, Tristina N, Surayana N. (2010). “Clinical Pathology and Majalah Pathology Klinik Indonesia dan Laboratorium Medik.â€Jurnal Indonesia 16(3): 55–104.

Gautam S, Cohen AJ, Stahl Y, Valda Toro P, Young GM, Datta R, et al. Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia. Thorax. 2020;75(11):974–81.

Ghazeeri G, Abdullah L, Abbas O. Immunological differences In women compared with men: overview and contributing factors. Am J Reprod Immunol 2011; 66: 163–169

Gunardi, W. D. (202). Pemeriksaan Diagnosis Laboratorium COVID-19: Keterbatasan dan Tantangannya Saat Ini. Jurnal Kedokteran Meditek. Vol: 27, No. 2: 173–182. Dilihat 26 September 2020. https://doi.org/10.36452/ jkdoktmeditek.v27i2.2036

Hastuti, Nuri, and Sitti Nur Djanah. (2020). “Literature Review Study: Transmission and Prevention of the Spread of Covid-19.â€Jurnal Kesehatan Masyarakat7(2): 70–79. https://ojs.uniska-bjm.ac.id/index.php/ANN/article/view/2984.

Hatherill M., Tibby SM., Sykes K., Turner C., Murdoch.,:Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child, 1999, 81:417–21.

Hayıroğlu Mİ, Çınar T, Tekkeşin Aİ. Varian fibrinogen dan D-dimer dan rekomendasi antikoagulan pada Covid-19: tinjauan literatur saat ini . Rev Assoc Méd Bras . 2020; 66 ( 6 ):842-848. Epub 20 Juli 2020 DOI: 10.1590/1806-9282.66.6.842 10.1590/1806-9282.66.6.842.

Karo, Marni Br. (2012). “Perilaku Hidup Bersih Dan Sehat (PHBS) Strategi Pencegahan Penyebaran Virus Covid-19.†: 1–4.

Kemenkes RI. (2021). PetaSebaran|Covid19.go.id. https://covid19.go.id/petasebaran

Li HY, Wang JW, Xu LW, Zhao XL, Feng JX, Xu YZ. Clinical analysis of 132 cases COVID-19 from Wuhan. Medicine (Baltimore). 2020;99(44):e22847.

Meisner M. Procalcitonin -Biochemistry and Clinical Diagnosis. 1st edition. Bremen: UNI-MED; (2010).

Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. (2001); 86: 396-404

Nurdin1, Andi Natasya Salzabilah2, Rahman3, Hurustiaty. (2021). “Analisis Faktor-Faktor Koagulasi pada Pasien Covid-19 di Rumah Sakit Universitas Hasanuddin.â€Jurnal Media Analis Kesehatan 12(2): 56–65.

Potus F, Mai V, Lebret M, dkk. 319 . Masyarakat Fisiologi Amerika; 2020:L277. 10.1152/ajplung.00195.2020. Wawasan Baru tentang Konsekuensi Vaskular Paru dari COVID-19 Am J Physiol Lung Cell Mol Physiol 2

Seftiya, Aulia and Kosala , Khemasili. (2021). Epidemiology Characteristics of Covid-19 Patients in North Kalimantan. 5, Kalimantan : Jurnal Sains dan Kesehatan, 2021, Vol. 3. ISSN .

Sukapura, D I Rsij. (2021). “Gambaran C-Reactive Protein (Crp) padaPasien Positif Covid-19.â€

Supit, Brigita. (2021). “Prokalsitonin, D-Dimer, dan Ferritin Sebagai Prediktor Perburukan COVID-19.â€Cdk 48(11): 357–60.

Susilo, A., Rumende, C. M., Pitoyo, C. W., Santoso, W. D., et al. (2020). Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia. Vol 7, No. 1: 45. https://doi.org/10.7454/jpdi.v7i1.415

Tang, N.,Li, D.,& Wang, X. (2020).Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.J. Thromb. Haemost, 18(4), 844-847.

Tim May, Malcolm Williams, Richard Wiggins, and Prof. Alan Bryman. (2021). “Latar Belakang Coronavirus Disease – 19 (COVID-19).†19(1996): 6.

Weitz JI, Fredenburgh JC, Eikelboom JW. Tes dalam Konteks: D-Dimer . J Am CollCardiol . (2017); 70 ( 19 ):2411-2420. doi: 10.1016/j.jacc.2017.09.024

Willim, H. A., Hardigaloeh, A. T. and Supit, A. I. (2020) ‘Koagulopati pada Coronavirus Disease -2019 (Covid-19): Tinjauan pustaka’, 11(3), pp. 749–756. doi: 10.15562/ism.v11i3.766.

Yanti, Budi, Fitri Dewi Ismida, and Klarina Elsa Siti Sarah. (2020). “Perbedaan Uji Diagnostik Antigen, Antibodi, RT-PCR Dan Tes Cepat Molekuler Pada Coronavirus Disease 2019.â€Jurnal Kedokteran Syiah Kuala 20(3): 172–77.

Yu B, Li X, Chen J, dkk. Evaluasi variasi kadar D-dimer antara COVID-19 dan pneumonia bakterial: analisis retrospektif . J Trombolisis Trombolisis . (2020); 50 ( 3 ):548-557. doi: 10.1007/s11239-020-02171-y.

https://Muamala.net/kategori-umur-menurut-who/

Downloads

Published

2024-03-30

How to Cite

Permata, K. G., Nurdiani, C. U., Nugroho, H. P., & Susanti, E. (2024). Gambaran Hasil Procalcitonin dan D-Dimer Pada Pasien Covid-19 Di RSUD Budhi Asih Jakarta Timur . Anakes : Jurnal Ilmiah Analis Kesehatan, 10(1), 20–28. https://doi.org/10.37012/anakes.v10i1.2088

Citation Check